SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001479290-16-000057
Filing Date
2016-11-04
Accepted
2016-11-04 16:11:19
Documents
62
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rvncq31610q.htm 10-Q 1165132
2 EXHIBIT 31.1 rvnc-q316exhibit311.htm EX-31.1 13583
3 EXHIBIT 31.2 rvnc-q316exhibit312.htm EX-31.2 13480
4 EXHIBIT 32.1 rvnc-q316exhibit321.htm EX-32.1 6250
5 EXHIBIT 32.2 rvnc-q316exhibit322.htm EX-32.2 6275
  Complete submission text file 0001479290-16-000057.txt   4844323

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rvnc-20160930.xml EX-101.INS 975555
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvnc-20160930.xsd EX-101.SCH 35796
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvnc-20160930_cal.xml EX-101.CAL 68240
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvnc-20160930_def.xml EX-101.DEF 125800
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvnc-20160930_lab.xml EX-101.LAB 438441
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvnc-20160930_pre.xml EX-101.PRE 259900
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36297 | Film No.: 161975286
SIC: 2834 Pharmaceutical Preparations